Guidelines

BASHH Clinical Effectiveness Group Guidelines (last updated 23rd Dec 2009 )

Also see the Clinical Effectiveness Group page (and the FFPRHC Page).

  • Guidelines accepted by National Guideline Clearing House.
  • Copyright: most of these guidelines have appeared in print and the copyright belongs to the original publishers (see notice below). They can be freely used for purposes of personal study and education.

WHAT'S NEW ?

  • The Clinical Standards and Management of acquired syphilis in HIV+ve patients (2002) documents have now been moved to the CEG Guidelines Archive
  • The 2009 draft Epididymo-orchitis guideline is now out for public consultation(see below)
  • Oct 2009 guidance on the reporting of acute hepatitis A, B and C may be accessed here: Reporting of Acute Hepatitis A B and C
  • The BASHH National Audit Group has produced a set of audit proformas for conducting audit on certain CEG guidelines. They may be accessed here http://www.bashh.org/groups/national_audit_group

DRAFT GUIDELINES

The following draft guideline(s) are out for wider consultation for a period of 3 months from the time of posting. Please contact the CEG Guideline Lead if you have any comments.

Posted Jan 12th 2010. Consultation ends April 12th 2010. Comments should be sent to Dr Mark Fitzgerald: GU.Med@tst.nhs.uk

Posted Oct 31st 2009. Consultation ends January 31st 2010. Comments may be sent to the guideline lead, Dr Keith Radcliffe: keith.w.radcliffe@hobtpct.nhs.uk

CURRENT GUIDELINES ( All previous BASHH CEG guidelines may now be accessed on the BASHH Guidelines Archive page )

Urethritis

Vaginal discharge

Genital ulceration

Management of chancroid [2007]

Management of donovanosis [2001]

Management of LGV [2006]
NB: Current HPA guidance on the diagnosis of LGV

Systemic presentation and complications

HIV

Skin conditions

Miscellaneous

Standards

  • Guideline Specifications document [2005]
    A paper has been prepared to assist the authors of the national guidelines in standardising their documents to the format/layout preferred by the CEG. (published in Int J STD& AIDS). Please note: as of October 2009 the membership of the CEG is Dr Keith Radcliffe (Chair) , Dr David Daniels, Dr Mark FitzGerald, Dr Margaret Kingston,Dr Neil Lazaro,Dr Gill McCarthy and Dr Ann Sullivan

Disclaimer Notice
The editors have checked with sources believed to be reliable in their efforts to eliminate error and to provide drug treatment schedules and dosages that are complete and accord with the standards accepted at the time of publication. However, readers are strongly advised to check the information provided is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.

Copyright Notice
Most of these guidelines were originally published in Sexually Transmitted Infections, and the copyright belongs to BMJ Publishing Group (BMJPG). Readers wishing to download and reproduce material for purposes other than personal study or education should contact BMJPG to seek permission first. Contact: BMJ Publishing Group, BMA House, Tavistock Square, WC1H 9JR, UK.
Some guidelines were originally published in the International Journal of STD & AIDS. These may be used for non commercial purposes but an acknowledgement of the source must be included, together with a link to http://ijsa.rsmjournals.com/ Any enquiries concerning reprints or usage of the electronic versions by commercial websites should be made to Royal Society of Medicine Press, 1 Wimpole Street , London W1G OAE.

Citations
When citing the guidelines on the web, please give the full title of the guideline, followed by the name/names of the author(s) (in the same way as for paper publications), followed by the full web address and the date when it was accessed. E.g., National Guideline on the Management of Non-gonococcal Urethritis. Horner P J, Shahmanesh M. www.bashh.org/guidelines/2002/NGU 09 01c.pdf[accessed 22 July 2004].